230 related articles for article (PubMed ID: 20686024)
1. The human papillomavirus type 16 E5 oncoprotein inhibits epidermal growth factor trafficking independently of endosome acidification.
Suprynowicz FA; Krawczyk E; Hebert JD; Sudarshan SR; Simic V; Kamonjoh CM; Schlegel R
J Virol; 2010 Oct; 84(20):10619-29. PubMed ID: 20686024
[TBL] [Abstract][Full Text] [Related]
2. The E5 oncoprotein of human papillomavirus type 16 inhibits the acidification of endosomes in human keratinocytes.
Straight SW; Herman B; McCance DJ
J Virol; 1995 May; 69(5):3185-92. PubMed ID: 7707548
[TBL] [Abstract][Full Text] [Related]
3. Binding of human papillomavirus 16 E5 to the 16 kDa subunit c (proteolipid) of the vacuolar H+-ATPase can be dissociated from the E5-mediated epidermal growth factor receptor overactivation.
RodrÃguez MI; Finbow ME; Alonso A
Oncogene; 2000 Aug; 19(33):3727-32. PubMed ID: 10949926
[TBL] [Abstract][Full Text] [Related]
4. The human papillomavirus type 16 E5 oncoprotein synergizes with EGF-receptor signaling to enhance cell cycle progression and the down-regulation of p27(Kip1).
Pedroza-Saavedra A; Lam EW; Esquivel-Guadarrama F; Gutierrez-Xicotencatl L
Virology; 2010 Apr; 400(1):44-52. PubMed ID: 20144468
[TBL] [Abstract][Full Text] [Related]
5. The BPV-1 E5 protein, the 16 kDa membrane pore-forming protein and the PDGF receptor exist in a complex that is dependent on hydrophobic transmembrane interactions.
Goldstein DJ; Andresson T; Sparkowski JJ; Schlegel R
EMBO J; 1992 Dec; 11(13):4851-9. PubMed ID: 1334459
[TBL] [Abstract][Full Text] [Related]
6. A glutamine residue in the membrane-associating domain of the bovine papillomavirus type 1 E5 oncoprotein mediates its binding to a transmembrane component of the vacuolar H(+)-ATPase.
Goldstein DJ; Kulke R; Dimaio D; Schlegel R
J Virol; 1992 Jan; 66(1):405-13. PubMed ID: 1370089
[TBL] [Abstract][Full Text] [Related]
7. Golgi alkalinization by the papillomavirus E5 oncoprotein.
Schapiro F; Sparkowski J; Adduci A; Suprynowicz F; Schlegel R; Grinstein S
J Cell Biol; 2000 Jan; 148(2):305-15. PubMed ID: 10648563
[TBL] [Abstract][Full Text] [Related]
8. The E5 oncoprotein of human papillomavirus type 16 transforms fibroblasts and effects the downregulation of the epidermal growth factor receptor in keratinocytes.
Straight SW; Hinkle PM; Jewers RJ; McCance DJ
J Virol; 1993 Aug; 67(8):4521-32. PubMed ID: 8392596
[TBL] [Abstract][Full Text] [Related]
9. The HPV16 E5 oncogene inhibits endocytic trafficking.
Thomsen P; van Deurs B; Norrild B; Kayser L
Oncogene; 2000 Dec; 19(52):6023-32. PubMed ID: 11146554
[TBL] [Abstract][Full Text] [Related]
10. Cyclophilins facilitate dissociation of the human papillomavirus type 16 capsid protein L1 from the L2/DNA complex following virus entry.
Bienkowska-Haba M; Williams C; Kim SM; Garcea RL; Sapp M
J Virol; 2012 Sep; 86(18):9875-87. PubMed ID: 22761365
[TBL] [Abstract][Full Text] [Related]
11. Vacuolar H(+)-ATPase mutants transform cells and define a binding site for the papillomavirus E5 oncoprotein.
Andresson T; Sparkowski J; Goldstein DJ; Schlegel R
J Biol Chem; 1995 Mar; 270(12):6830-7. PubMed ID: 7896830
[TBL] [Abstract][Full Text] [Related]
12. HPV16 E5 affects the KGFR/FGFR2b-mediated epithelial growth through alteration of the receptor expression, signaling and endocytic traffic.
Belleudi F; Leone L; Purpura V; Cannella F; Scrofani C; Torrisi MR
Oncogene; 2011 Dec; 30(50):4963-76. PubMed ID: 21625213
[TBL] [Abstract][Full Text] [Related]
13. The human papillomavirus type 16 E5-protein modulates ligand-dependent activation of the EGF receptor family in the human epithelial cell line HaCaT.
Crusius K; Auvinen E; Steuer B; Gaissert H; Alonso A
Exp Cell Res; 1998 May; 241(1):76-83. PubMed ID: 9633515
[TBL] [Abstract][Full Text] [Related]
14. beta(1) integrin binds the 16-kDa subunit of vacuolar H(+)-ATPase at a site important for human papillomavirus E5 and platelet-derived growth factor signaling.
Skinner MA; Wildeman AG
J Biol Chem; 1999 Aug; 274(33):23119-27. PubMed ID: 10438481
[TBL] [Abstract][Full Text] [Related]
15. A mutagenic analysis of the E5 protein of human papillomavirus type 16 reveals that E5 binding to the vacuolar H+-ATPase is not sufficient for biological activity, using mammalian and yeast expression systems.
Adam JL; Briggs MW; McCance DJ
Virology; 2000 Jul; 272(2):315-25. PubMed ID: 10873774
[TBL] [Abstract][Full Text] [Related]
16. The human papillomavirus type 16 E5 protein alters vacuolar H(+)-ATPase function and stability in Saccharomyces cerevisiae.
Briggs MW; Adam JL; McCance DJ
Virology; 2001 Feb; 280(2):169-75. PubMed ID: 11162831
[TBL] [Abstract][Full Text] [Related]
17. The human papillomavirus type 16 E5 oncoprotein translocates calpactin I to the perinuclear region.
Krawczyk E; Suprynowicz FA; Hebert JD; Kamonjoh CM; Schlegel R
J Virol; 2011 Nov; 85(21):10968-75. PubMed ID: 21849434
[TBL] [Abstract][Full Text] [Related]
18. The BPV-1 E5 oncoprotein expressed in Schizosaccharomyces pombe exhibits normal biochemical properties and binds to the endogenous 16-kDa component of the vacuolar proton-ATPase.
Goldstein DJ; Toyama R; Dhar R; Schlegel R
Virology; 1992 Oct; 190(2):889-93. PubMed ID: 1387753
[TBL] [Abstract][Full Text] [Related]
19. Bovine papillomavirus E5 oncoprotein binds to the 16K component of vacuolar H(+)-ATPases.
Goldstein DJ; Finbow ME; Andresson T; McLean P; Smith K; Bubb V; Schlegel R
Nature; 1991 Jul; 352(6333):347-9. PubMed ID: 1649407
[TBL] [Abstract][Full Text] [Related]
20. Quantitative measurement of human papillomavirus type 16 e5 oncoprotein levels in epithelial cell lines by mass spectrometry.
Sahab Z; Sudarshan SR; Liu X; Zhang Y; Kirilyuk A; Kamonjoh CM; Simic V; Dai Y; Byers SW; Doorbar J; Suprynowicz FA; Schlegel R
J Virol; 2012 Sep; 86(17):9465-73. PubMed ID: 22740411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
